|
 |
NEW PRODUCTS |
ACNEMIX |
|
ACNEMİX JEL |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D10AF52 |
|
Active Substance |
BENZOYL PEROXIDE ERYTHROMYCIN
|
|
Presentation |
Gel
|
|
|
|
|
|
 |
A-FERİN FORTE |
|
A-FERİN FORTE FİLM KAPLI TABLET |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05X |
|
Active Substance |
CHLORPHENIRAMINE MALEATE
PARACETAMOL
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
 |
A-FERİN HOT |
|
A-FERİN HOT TEK KULLANIMLIK TOZ İÇEREN POŞET |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05X |
|
Active Substance |
PARACETAMOL
PSEUDOEPHEDRINE HCL
|
|
Presentation |
Sachet
|
|
|
|
|
|
 |
A-FERİN KAPSÜL |
|
A-FERİN KAPSÜL |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05X |
|
Active Substance |
CHLORPHENIRAMINE MALEATE
CODEINE PHOSPHATE
PARACETAMOL
|
|
Presentation |
Capsules |
|
|
|
|
|
 |
ALZANT |
|
ALZANT 10 mg FİLM TABLET |
Therapeutical Group |
Nervous System
|
ATC Code |
N06DX01 |
|
Active Substance |
MEMANTINE
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
 |
ANTEPSİN |
|
ANTEPSİN SÜSPANSİYON |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A02BX02 |
|
Active Substance |
SUCRALFATE
|
|
Presentation |
Suspension
|
|
|
|
|
|
ANTEPSİN TABLET |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A02BX02 |
|
Active Substance |
SUCRALFATE
|
|
Presentation |
Tablets
|
|
|
|
|
|
 |
APİREKS |
|
APİREKS COLD&FLU 200mg/30mg FİLM KAPLI TABLET |
Therapeutical Group |
Respiratory system
|
ATC Code |
M01AE51 |
|
Active Substance |
PSEUDOEPHEDRINE HCL
IBUPROFEN
|
|
Presentation |
Tablets
|
|
|
|
|
|
APİREKS 100 mg/5 mL PEDİATRİK SÜSPANSİYON |
Therapeutical Group |
Musculo-skeletal system
|
ATC Code |
M01AE01 |
|
Active Substance |
IBUPROFEN
|
|
Presentation |
Pediatric suspension
|
|
|
|
|
|
 |
APRAZOL |
|
APRAZOL 30 mg MİKROPELLET KAPSÜL |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A02BC03 |
|
Active Substance |
LANSOPRAZOLE
|
|
Presentation |
Capsules
|
|
|
|
|
|
 |
APROL |
|
APROL FORT TABLET |
Therapeutical Group |
Musculo-skeletal system
|
ATC Code |
M01AE02 |
|
Active Substance |
NAPROXEN SODIUM
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
 |
ASEMAX |
|
ASEMAX 250 mg /5mL ORAL SÜSPANSİYON HAZIRLAMAK İÇİN KURU TOZ |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD15 |
|
Active Substance |
CEFDINIR
|
|
Presentation |
Oral suspension
|
|
|
|
|
|
ASEMAX 125 mg/5 mL ORAL SÜSPANSİYON HAZIRLAMAK İÇİN KURU TOZ |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD15 |
|
Active Substance |
CEFDINIR
|
|
Presentation |
Oral suspension
|
|
|
|
|
|
ASEMAX 300 mg FİLM KAPLI TABLET |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD15 |
|
Active Substance |
CEFDINIR
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
 |
ASİST |
|
ASİST 900 mg TOZ İÇEREN SAŞE |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB01 |
|
Active Substance |
ACETYLCISTEINE
|
|
Presentation |
Sachets
|
|
|
|
|
|
ASİST % 4 100 mL ŞURUP HAZIRLAMAK İÇİN 40 g GRANÜL |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB01 |
|
Active Substance |
ACETYLCISTEINE
|
|
Presentation |
Granules for pediatric syrop
|
|
|
|
|
|
ASİST % 4 150 mL ŞURUP HAZIRLAMAK İÇİN 60 g GRANÜL |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB01 |
|
Active Substance |
ACETYLCISTEINE
|
|
Presentation |
Granules for pediatric syrop
|
|
|
|
|
|
ASİST PLUS 600 mg TOZ İÇEREN SAŞE |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB01 |
|
Active Substance |
ACETYLCISTEINE
|
|
Presentation |
Sachets
|
|
|
|
|
|
ASİST 1200 mg TOZ İÇEREN SAŞE |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB01 |
|
Active Substance |
ACETYLCISTEINE
|
|
Presentation |
Sachets
|
|
|
|
|
|
ASİST 300 mg/3 mL SOLÜSYON İÇEREN AMPUL |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB01 |
|
Active Substance |
ACETYLCISTEINE
|
|
Presentation |
Ampoule |
|
|
|
|
|
 |
ATEROZ |
|
ATEROZ 10 mg FİLM TABLET |
Therapeutical Group |
Cardiovascular system
|
ATC Code |
C10AA05 |
|
Active Substance |
ATORVASTATIN CALCIUM
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
ATEROZ 20 mg FİLM TABLET |
Therapeutical Group |
Cardiovascular system
|
ATC Code |
C10AA05 |
|
Active Substance |
ATORVASTATIN CALCIUM
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
ATEROZ 40 mg FİLM TABLET |
Therapeutical Group |
Cardiovascular system
|
ATC Code |
C10AA05 |
|
Active Substance |
ATORVASTATIN CALCIUM
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
ATEROZ 80 mg FİLM TABLET |
Therapeutical Group |
Cardiovascular system
|
ATC Code |
C10AA05 |
|
Active Substance |
ATORVASTATIN CALCIUM
|
|
Presentation |
Film coated tablets
|
|
|
|
|
|
 |
BACODERM |
|
BACODERM % 2 KREM |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D06AX09 |
|
Active Substance |
MUPIROSIN
|
|
Presentation |
Cream
|
|
|
|
|
|
BACODERM CREAM |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D06A |
|
Active Substance |
MUPIROCIN
|
|
Presentation |
Cream |
|
|
|
|
|
BACODERM % 2 POMAD |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D06AX09 |
|
Active Substance |
MUPIROCIN
|
|
Presentation |
Ointment
|
|
|
|
|
|
 |
BEKLAZON |
|
BEKLAZON KREM |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D07AC15 |
|
Active Substance |
BECLOMETHASONE DIPROPIONATE
|
|
Presentation |
Cream |
|
|
|
|
|
 |
BİLFASİN |
|
BİLFASİN 1 g FİLM KAPLI TABLET |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DA01 |
|
Active Substance |
SEFALEKSİN
|
|
Presentation |
10, 16 ve 20 Film Kaplı Tablet |
|
|
|
|
|
 |
BRIMOGUT |
|
BRİMOGUT % 0.15 GÖZ DAMLASI |
Therapeutical Group |
Sensory organs
|
ATC Code |
S01EA05 |
|
Active Substance |
BRIMONIDIN
|
|
Presentation |
Eye Drops |
|
|
|
|
|
 |
CEFTİNEX |
|
CEFTİNEX 600 mg FİLM KAPLI TABLET |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD15 |
|
Active Substance |
SEFDINIR
|
|
Presentation |
Film tablets |
|
|
|
|
|
CEFTİNEX 250 mg/5 mL ORAL SÜSPANSİYON HAZIRLAMAK İÇİN KURU TOZ |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD15 |
|
Active Substance |
CEFDINIR
|
|
Presentation |
Oral suspension |
|
|
|
|
|
 |
FORTİNE |
|
FORTİNE SR 200 mg UZATILMIŞ SALIMLI KAPSÜL |
Therapeutical Group |
Musculo-skeletal system
|
ATC Code |
M01AE09 |
|
Active Substance |
FLURBIPROFEN
|
|
Presentation |
Capsule |
|
|
|
|
|
 |
FUCITEC |
|
FUCİTEC %1 VİSKOZ GÖZ DAMLASI |
Therapeutical Group |
Eye Products
|
ATC Code |
S01AA13 |
|
Active Substance |
FUSIDIC ACID
|
|
Presentation |
5 g Göz Damlası |
|
|
|
|
|
FUCİTEC PLUS KREM |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D07CC01 |
|
Active Substance |
FUSIDIC ACID, BETAMETHASONE VALERATE
|
|
Presentation |
Cream |
|
|
|
|
|
FUCİTEC 500 mg FİLM KAPLI TABLET |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01XC01 |
|
Active Substance |
SODIUM FUSIDATE
|
|
Presentation |
Film Tablets |
|
|
|
|
|
FUCİTEC %2 POMAD |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D06AX01 |
|
Active Substance |
FUSIDIC ACID
|
|
Presentation |
Pomade |
|
|
|
|
|
FUCİTEC %2 KREM |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D06AX01 |
|
Active Substance |
FUSIDIC ACID
|
|
Presentation |
Cream |
|
|
|
|
|
 |
IBOFIX |
|
İBOFİX 150 mg FİLM KAPLI TABLET |
Therapeutical Group |
Musculo-skeletal system
|
ATC Code |
M05BA06 |
|
Active Substance |
IBANDRONIC ACID
|
|
Presentation |
Film coated tablets |
|
|
|
|
|
 |
KLAVON |
|
KLAVON BID 1000 mg FİLM KAPLI TABLET |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01CR02 |
|
Active Substance |
AMOXICILLIN CLAVULANIC ACID
|
|
Presentation |
Tablets |
|
|
|
|
|
KLAVON ES 600 mg/42.9 mg ORAL SÜSPANSİYON HAZIRLAMAK İÇİN KURU TOZ |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01CR02 |
|
Active Substance |
AMOXICILLIN CLAVULANIC ACID
|
|
Presentation |
Suspension |
|
|
|
|
|
 |
LEODEX |
|
LEODEX % 1,25 mg JEL |
Therapeutical Group |
Musculo-skeletal system
|
ATC Code |
M01AE17 |
|
Active Substance |
DEXKETOPROFEN TROMETAMOL
|
|
Presentation |
Gel |
|
|
|
|
|
 |
LEVOKAST |
|
LEVOKAST 5 mg/10 mg FİLM KAPLI TABLET |
Therapeutical Group |
Respiratory system
|
ATC Code |
R06AK |
|
Active Substance |
LEVOSETİRİZİN
MONTELUKAST
|
|
Presentation |
30 ve 90 tablet |
|
|
|
|
|
 |
MIXOVUL |
|
MİXOVUL OVÜL |
Therapeutical Group |
Gynecology
|
ATC Code |
G01AF20 |
|
Active Substance |
MIKONAZOL METRONIDAZOL LIDOKAIN
|
|
Presentation |
Vaginal Insert |
|
|
|
|
|
 |
OFTOMIX |
|
OFTOMİX GÖZ DAMLASI |
Therapeutical Group |
Sensory organs
|
ATC Code |
S01ED51 |
|
Active Substance |
DORZOLAMID TIMOLOL
|
|
Presentation |
Eye drops |
|
|
|
|
|
 |
OLADİN |
|
OLADİN % 0.1 GÖZ DAMLASI |
Therapeutical Group |
Eye Products
|
ATC Code |
S01GX09 |
|
Active Substance |
OLOPATADİN
|
|
Presentation |
Eye drops |
|
|
|
|
|
 |
RUPATEK |
|
RUPATEK 10 mg TABLET |
Therapeutical Group |
Respiratory system
|
ATC Code |
R06AX28 |
|
Active Substance |
RUPATADİN
|
|
Presentation |
20 ve 30 Tablet |
|
|
|
|
|
 |
STİDERM |
|
STİDERM JEL |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D04AB01 |
|
Active Substance |
MEPYRAMINE MALEATE, LIDOCAIN HYDROCHLORIDE, DEXPANTHENOL
|
|
Presentation |
Gel |
|
|
|
|
|
 |
TORK |
|
TORK 20 mg FİLM KAPLI TABLET |
Therapeutical Group |
Urology
|
ATC Code |
G04BE08 |
|
Active Substance |
TADALAFIL
|
|
Presentation |
Film Tablets |
|
|
|
|
|
 |
VENTOPİUM PLUS |
|
VENTOPİUM PLUS 0.5 mg/2.5 mg/2.5 mL NEBÜLİZASYON İÇİN İNH. ÇÖZ. |
Therapeutical Group |
Respiratory system
|
ATC Code |
R03AK04 |
|
Active Substance |
SALBUTAMOL
İPRATROPİUM
|
|
Presentation |
20 Flakon |
|
|
|
|
|
 |
VENTOSAL |
|
VENTOSAL 2.5 mg/2.5 mL NEBÜLİZASYON İÇİN İNH. ÇÖZ. |
Therapeutical Group |
Respiratory system
|
ATC Code |
R03AC02 |
|
Active Substance |
SALBUTAMOL
|
|
Presentation |
20 Flakon |
|
|
|
|
|
 |
ZESPİRA |
|
ZESPİRA 4 mg PEDİYATRİK ORAL GRANÜL İÇEREN SAŞE |
Therapeutical Group |
Respiratory system
|
ATC Code |
R03DC03 |
|
Active Substance |
MONTELUKAST SODIUM
|
|
Presentation |
Sachets |
|
|
|
|
|
ZESPIRA GRANULE |
Therapeutical Group |
Respiratory system
|
ATC Code |
R03J2 |
|
Active Substance |
MONTELUKAST SODIUM
|
|
Presentation |
Granules Bottle |
|
|
|
|
|
 |
ZİMAKS |
|
ZİMAKS 100 mg/5 mL ORAL SÜSPANSİYON HAZIRLAMAK İÇİN KURU TOZ (pediyatrik kullanım için) |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD08 |
|
Active Substance |
CEFIXIME
|
|
Presentation |
Suspension |
|
|
|
|
|
 |
|
|
|